Tags » MDR-TB

London advanced TB course and free evening symposium

The London Advanced TB Course is taking place Nov 10-11th.

It is organised by Public Health England with the Centre for Respiratory Infection (CRI), National Heart and Lung Institute at Imperial College London. 203 more words


India needs to work aggressively to combat MDR-TB

Tuberculosis has been and still is a menace worldwide. With nearly one-third of the population infected with Mycobacterium Tuberculosis, TB is the second most reason of death from infectious disease after HIV with Asia and Africa contributing to the maximum number of fatalities. 734 more words

Did WHO’s TB care advice cause more MDR-TB cases?

Between 1993 and 2002, the World Health Organisation violated sound medical care by urging low- and middle-income countries to follow less expensive, largely untested and ineffective treatment protocols to treat people with multidrug resistant TB (MDR-TB), says a… 681 more words

World Health Organisation

The World Health Organization (WHO) has issued new conditional recommendations for the use of a shorter treatment regimen in patients with Multidrug-Resistant Tuberculosis (MDR-TB).

Background Information: 496 more words


Drug Resistant TB Detection No Longer A Sluggish Affair

The day is not far when the diagnosis of TB, both simple and drug-resistant will be buttoned up, all in a day’s span. ‘Diagnose and start treatment within a day’-this is the new mantra the Union Ministry of Health has come up with in order to put a check on the cases of Drug Resistant Tuberculosis (DR-TB) in the country. 368 more words


A step closer to a safer, more efficacious TB vaccine

A potent vaccine against tuberculosis is getting readied at the Pune-based Serum Institute of India Limited. The institute started a ‘Phase 2b’ clinical trial in neonates in South Africa late last year using a novel, recombinant BCG (bacillus Calmette-Guérin) vaccine. 799 more words

Clinical Trial

Pilot testing of bedaquiline drug on TB patients to start soon

A pilot programme to test the toxicity, particularly cardio-toxicity, of bedaquiline drug (used for combating multidrug-drug resistant TB) in the Indian population, assess its ability to achieve culture conversion and check the operational feasibility of using the drug to treat MDR-TB patients would start in India by the end of this month or on World TB day. 282 more words

World Health Organisation